March 3, 2017 / 5:15 AM / 5 months ago

BRIEF-Alembic Pharmaceuticals says launch of depression treating drug by Breckenridge Pharma

1 Min Read

March 3 (Reuters) - Alembic Pharmaceuticals Ltd

* Says launch of Desvenlafaxine Succinate extended release tablets by partner Breckenridge Pharma

* Says drug indicated for treatment of major depressive disorder Source text: (bit.ly/2mMvXfL) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below